Acumen Pharmaceuticals In...
(ABOS)
undefined
undefined%
At close: undefined
2.03
0.00%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -52.37M | -42.86M | -100.61M | -7.33M | -7.91M |
| Depreciation & Amortization | 184.00K | 169.00K | 4.00K | - | - |
| Stock-Based Compensation | 6.14M | 3.06M | 922.00K | 154.00K | 174.00K |
| Other Working Capital | 4.13M | 3.43M | -259.00K | -1K | 658.00K |
| Other Non-Cash Items | -888.00K | 487.00K | 81.27M | -586.00K | 147.00K |
| Deferred Income Tax | - | - | 155.00K | - | - |
| Change in Working Capital | 3.87M | 3.99M | 298.00K | 307.00K | 768.00K |
| Operating Cash Flow | -43.06M | -35.15M | -17.96M | -7.45M | -6.82M |
| Capital Expenditures | -21.00K | -161.00K | -40.00K | - | - |
| Acquisitions | - | -39.35K | - | - | - |
| Purchase of Investments | -250.63M | -41.51M | -104.08M | - | - |
| Sales Maturities Of Investments | 78.98M | 80.86M | - | - | - |
| Other Investing Acitivies | 3.00K | 39.35K | -104.08K | - | - |
| Investing Cash Flow | -171.67M | 39.19M | -104.12M | - | - |
| Debt Repayment | 30.00M | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | -151.00K | 115.00K | 31.91M | 44.67M | 6.24M |
| Financial Cash Flow | 151.75M | 3.91M | 200.47M | 44.67M | 6.24M |
| Net Cash Flow | -62.98M | 7.94M | 78.39M | 37.23M | -579.00K |
| Free Cash Flow | -43.09M | -35.31M | -18.00M | -7.45M | -6.82M |